Form 4: Bio-Rad Laboratories President Receives Stock Grant
Insider Transaction (Form 4)
James Barry, EVP, President, LSG of Bio-Rad Laboratories, Inc., reported multiple transactions in common stock on September 4, 2026.
Summary
- Option exercise/conversion: acquired 1,027 Bio-Rad A Common Stock on September 5, 2026; holds 1,808 after (Direct).
- Tax/exercise-price withholding: disposed of 369 Bio-Rad A Common Stock at $386.11 ($142,475) on September 5, 2026; holds 1,439 after (Direct).
- Option exercise/conversion: acquired 1,056 Bio-Rad A Common Stock on September 6, 2026; holds 2,495 after (Direct).
- Tax/exercise-price withholding: disposed of 470 Bio-Rad A Common Stock at $386.11 ($181,472) on September 6, 2026; holds 2,025 after (Direct).
- Grant/award: acquired 4,313 Restricted Stock Units on September 4, 2026; holds 4,313 after (Direct).
- Option exercise/conversion: disposed of 1,027 Restricted Stock Units on September 5, 2026; holds 3,083 after (Direct).
- Option exercise/conversion: disposed of 1,056 Restricted Stock Units on September 6, 2026; holds 2,112 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
James Barry — Officer (EVP, President, LSG)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-05 | Option exercise/conversion | Bio-Rad A Common Stock | 1,027 | — | — | 1,807.682 |
| 2026-09-05 | Tax/exercise-price withholding | Bio-Rad A Common Stock | 369 | $386 | $142.5K | 1,438.682 |
| 2026-09-06 | Option exercise/conversion | Bio-Rad A Common Stock | 1,056 | — | — | 2,494.682 |
| 2026-09-06 | Tax/exercise-price withholding | Bio-Rad A Common Stock | 470 | $386 | $181.5K | 2,024.682 |
| 2026-09-04 | Grant/award | Restricted Stock Units | 4,313 | — | — | 4,313 |
| 2026-09-05 | Option exercise/conversion | Restricted Stock Units | 1,027 | — | — | 3,083 |
| 2026-09-06 | Option exercise/conversion | Restricted Stock Units | 1,056 | — | — | 2,112 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-05 | Option exercise/conversion (1,027 shares) |
| 2026-09-05 | Tax/exercise-price withholding (369 shares) |
| 2026-09-06 | Option exercise/conversion (1,056 shares) |
| 2026-09-06 | Tax/exercise-price withholding (470 shares) |
| 2026-09-04 | Grant/award (4,313 shares) |
| 2026-09-05 | Option exercise/conversion (1,027 shares) |
| 2026-09-06 | Option exercise/conversion (1,056 shares) |
Keywords
insider transaction, Form 4, BIO BIO.B, BIO-RAD LABORATORIES, INC., neutral, James Barry
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.